While Angela originally trained as a computer scientist, she always dreamed of working on treatments that could improve the lives of patients. This inspired her to complete her master’s and Ph.D. in Computational Biology at MIT and the Broad Institute, and to then join Vertex as a Computational Genomics Scientist.
Angela is now the Vice President of Data and Computational Sciences at Vertex Pharmaceuticals in Boston, MA. Her Data and Computational Sciences team leads the development and application of AI and advanced analytics across the global Research portfolio to answer critical scientific questions. The team’s work spans across many technologies and areas, including computational chemistry, genomics, imaging, machine learning, statistics, integrative data science, and biopharmaceutics modeling. For example, Angela’s team previously led the development of the computational framework used to evaluate on-target and off-target gene editing for our cell and gene therapy programs.
Angela was previously named a Rising Star by the Healthcare Businesswomen’s Association and was a Siebel Scholar, Google Anita Borg Scholar, a United States Presidential Scholar and a STAT Wunderkind. Her work has been published in the New England Journal of Medicine, Nature and Cell. Angela is not only a rock star computational scientist, but she is also a highly effective, intelligent and engaging colleague. She brings passion, intellect and enthusiasm to every project she works on and she possesses a deep understanding of the drug development process. She is humble and considerate, yet bold and audacious when defending a scientific argument. Angela sets a high bar for what’s possible.